FDA Rejects the Psychedelic MDMA as a PTSD Treatment ...Middle East

Time - News
FDA Rejects the Psychedelic MDMA as a PTSD Treatment
WASHINGTON — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using mind-altering substances to treat serious mental health conditions. Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based on data submitted to date,” and requested an additional late-stage study. Such studies generally takes several years and millions of dollars to conduct. The company said it plans to ask the agency to reconsider. [time-brightcove not-tgx=”true”] Lykos and other psychedelic companies had hoped that MDMA would be appr

Hence then, the article about fda rejects the psychedelic mdma as a ptsd treatment was published today ( ) and is available on Time ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Rejects the Psychedelic MDMA as a PTSD Treatment )

Apple Storegoogle play

Last updated :

Also on site :